SOURCE: EnWave Corporation

EnWave Corporation

May 20, 2015 09:00 ET

EnWave Confirms Successful Machine Installation and Commercial Start-Up at Natural Nutrition Limited

VANCOUVER, BC--(Marketwired - May 20, 2015) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") is pleased to confirm the successful installation and start-up of a Radiant Energy Vacuum ("REV™") machine at the facilities of Natural Nutrition Limited ("Natural Nutrition"), a Chilean fruit processor focused on the production of high-quality, nutrient-rich products. Natural Nutrition holds an exclusive license to use REV™ technology for the dehydration of several specific fruit products in Chile, including blueberries and maquiberry.

Natural Nutrition has projected growth of at least of 50 tons of finished product per year over the next four years, both as whole dried fruit and powder. With the implementation of REV™ technology, Natural Nutrition aims to position itself as a benchmark and leader in Chile, Latin America and the world for the production of snack fruit, nutraceuticals and functional ingredients.

EnWave currently has four licenses signed with partners for the commercial production of high-quality fruit products using REV™ technology.

About Natural Nutrition Limited
Natural Nutrition is a Chilean company focused on the dehydration of fruit, especially berries and native species of Chile and Patagonia, such as maquiberry and others. The mission of Natural Nutrition is to process the healthiest raw materials with high nutritional quality from the fields and forests of this region. The combination of using optimal raw materials and appropriate dehydration technology, will allow Natural Nutrition to preserve superior nutritional content, flavor and aroma from the fresh fruits.

About EnWave
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV™) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. Thus far the Company has signed thirteen royalty-bearing licenses, opening up eight distinct market sectors for commercialization with companies. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.

EnWave is introducing REV™ as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms: nutraREV® is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; powderREV® is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point and quantaREV® is used for continuous, high-volume low-temperature drying. Two additional platforms, bioREV® and freezeREV®, are being developed as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation
Dr. Tim Durance
President, CEO and Director

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • For further information:

    Mr. John Budreski
    Executive Chairman
    EnWave Corporation
    +1 (416) 930-0914
    E-mail: jbudreski@enwave.net

    Mr. Brent Charleton
    Senior Vice President, Corporate Affairs
    +1 (778) 378-9616
    E-mail: bcharleton@enwave.net